دورية أكاديمية

Rationale and design of a phase II trial of dacomitinib in advanced non-small cell lung cancer patients with uncommon epidermal growth factor receptor mutations: a prospective and single arm study (DANCE study)

التفاصيل البيبلوغرافية
العنوان: Rationale and design of a phase II trial of dacomitinib in advanced non-small cell lung cancer patients with uncommon epidermal growth factor receptor mutations: a prospective and single arm study (DANCE study)
المؤلفون: Zhang, Bo, Shi, Chunlei, Gao, Zhiqiang, Zhong, Hua, Xiong, Liwen, Gu, Aiqin, Wang, Weimin, Chu, Tianqing, Zhang, Wei, Wang, Huimin, Zhang, Xueyan, Zhong, Runbo, Han, BaohuiAff1, IDs12885022094093_cor13
المصدر: BMC Cancer. 22(1)
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:14712407
DOI:10.1186/s12885-022-09409-3